JP2025507852A5 - - Google Patents
Info
- Publication number
- JP2025507852A5 JP2025507852A5 JP2024551975A JP2024551975A JP2025507852A5 JP 2025507852 A5 JP2025507852 A5 JP 2025507852A5 JP 2024551975 A JP2024551975 A JP 2024551975A JP 2024551975 A JP2024551975 A JP 2024551975A JP 2025507852 A5 JP2025507852 A5 JP 2025507852A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- pharmaceutically acceptable
- acceptable salt
- compound according
- aforementioned
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263315438P | 2022-03-01 | 2022-03-01 | |
| US63/315,438 | 2022-03-01 | ||
| US202363439477P | 2023-01-17 | 2023-01-17 | |
| US63/439,477 | 2023-01-17 | ||
| PCT/US2023/014275 WO2023167925A1 (en) | 2022-03-01 | 2023-03-01 | Medium- or macro-cyclic benzyl-substituted heterocycle derivatives and related uses |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025507852A JP2025507852A (ja) | 2025-03-21 |
| JP2025507852A5 true JP2025507852A5 (cg-RX-API-DMAC7.html) | 2026-03-10 |
Family
ID=85772026
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024551975A Pending JP2025507852A (ja) | 2022-03-01 | 2023-03-01 | 中環状または大環状ベンジル置換複素環誘導体および関連の使用 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US20250236629A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4486748A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2025507852A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240157067A (cg-RX-API-DMAC7.html) |
| CN (1) | CN119110802A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2023228830A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3245204A1 (cg-RX-API-DMAC7.html) |
| CL (1) | CL2024002576A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL315237A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2024010608A (cg-RX-API-DMAC7.html) |
| TW (1) | TW202400606A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023167925A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12503475B2 (en) | 2020-09-03 | 2025-12-23 | Centessa Pharmaceuticals (Uk) Limited | Bicyclic-heterocycle derivatives and their uses as orexin-2 receptor agonists |
| WO2022207935A1 (en) | 2021-04-02 | 2022-10-06 | Orexia Therapeutics Limited | 2-(3-ethynylbenzyl)-substituted heterocycle derivatives as orexin-2 agonists |
| EP4680611A1 (en) | 2023-03-16 | 2026-01-21 | Takeda Pharmaceutical Company Limited | Macrocyclic heterocycle compounds and use thereof |
| JP2026518313A (ja) | 2023-06-01 | 2026-06-04 | ハー・ルンドベック・アクチエゼルスカベット | スピロ大環状オレキシン2受容体アゴニスト |
| CN122374291A (zh) | 2023-12-12 | 2026-07-10 | 爱杜西亚药品有限公司 | 作为食欲素受体调节剂的芳基砜及砜酮衍生物 |
| WO2025132542A1 (en) | 2023-12-19 | 2025-06-26 | Idorsia Pharmaceuticals Ltd | Macrocyclic orexin agonists |
| US20260144795A1 (en) | 2024-11-27 | 2026-05-28 | H. Lundbeck A/S | Spiromacrocyclic orexin 2 receptor agonists |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5763263A (en) | 1995-11-27 | 1998-06-09 | Dehlinger; Peter J. | Method and apparatus for producing position addressable combinatorial libraries |
| US10428023B2 (en) | 2017-08-03 | 2019-10-01 | Takeda Pharmaceutical Company Limited | Heterocyclic compound and use thereof |
| PE20211700A1 (es) | 2019-01-31 | 2021-09-01 | Takeda Pharmaceuticals Co | Compuesto heterociclico y su uso |
| KR20260083444A (ko) * | 2019-11-25 | 2026-06-05 | 알케르메스,인코포레이티드 | 치환된 마크로사이클릭 화합물 및 관련 치료 방법 |
| CN116635393A (zh) * | 2020-09-03 | 2023-08-22 | 欧瑞夏治疗有限公司 | 中环或大环苄基取代的杂环衍生物及其作为食欲素-2受体激动剂的用途 |
-
2023
- 2023-03-01 WO PCT/US2023/014275 patent/WO2023167925A1/en not_active Ceased
- 2023-03-01 KR KR1020247032615A patent/KR20240157067A/ko active Pending
- 2023-03-01 EP EP23713207.1A patent/EP4486748A1/en active Pending
- 2023-03-01 IL IL315237A patent/IL315237A/en unknown
- 2023-03-01 TW TW112107384A patent/TW202400606A/zh unknown
- 2023-03-01 JP JP2024551975A patent/JP2025507852A/ja active Pending
- 2023-03-01 MX MX2024010608A patent/MX2024010608A/es unknown
- 2023-03-01 CA CA3245204A patent/CA3245204A1/en active Pending
- 2023-03-01 CN CN202380037293.8A patent/CN119110802A/zh active Pending
- 2023-03-01 AU AU2023228830A patent/AU2023228830A1/en active Pending
-
2024
- 2024-08-28 US US18/817,943 patent/US20250236629A1/en active Pending
- 2024-08-29 CL CL2024002576A patent/CL2024002576A1/es unknown
-
2025
- 2025-04-11 US US19/177,396 patent/US20250289828A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023540350A5 (cg-RX-API-DMAC7.html) | ||
| JP2023540344A5 (cg-RX-API-DMAC7.html) | ||
| JP2023527575A5 (cg-RX-API-DMAC7.html) | ||
| JP4628974B2 (ja) | イバブラジン塩酸塩のγ−結晶形態、その製造方法およびそれを含む医薬組成物 | |
| JP2022545633A5 (cg-RX-API-DMAC7.html) | ||
| CN116438170A (zh) | 含氮桥杂环化合物、其制备方法及其在医药上的应用 | |
| JP2023502441A5 (cg-RX-API-DMAC7.html) | ||
| JP2021513967A5 (cg-RX-API-DMAC7.html) | ||
| JP2014528485A5 (cg-RX-API-DMAC7.html) | ||
| JPH06510030A (ja) | 新規な3,5−ジ−tert−ブチル−4− ヒドロキシフェニル誘導体、それらの製造方法および薬剤 | |
| JP2006504710A5 (cg-RX-API-DMAC7.html) | ||
| JP2022530989A5 (cg-RX-API-DMAC7.html) | ||
| NO338370B1 (no) | ß-krystallinsk form av ivabradin-hydroklorid, fremgangsmåte for dens fremstilling og farmasøytiske sammensetninger inneholdende den | |
| JPH0544946B2 (cg-RX-API-DMAC7.html) | ||
| JP2007112796A (ja) | 塩酸イバブラジンのδ結晶形態、その製造法、およびそれを含有する医薬組成物 | |
| RS50599B (sr) | KRISTALNI OBLIK BETA-d IVABRADIN HLORHIDRATA, POSTUPAK NJEGOVE IZRADE I FARMACEUTSKE SMEŠE KOJE GA SADRŽE | |
| JP2007519742A5 (cg-RX-API-DMAC7.html) | ||
| JPH02290841A (ja) | 新規化合物、その製法及びそれを含む医薬組成物 | |
| JP2022174180A (ja) | 化合物、組成物および方法 | |
| JPH07508973A (ja) | 血中酸素親和性の抑制のためのヘモグロビンのアロステリック修飾剤の使用 | |
| AU2021328979B2 (en) | Pyrazole boronic acid compound, pharmaceutical composition containing same, and uses thereof | |
| JP2022526827A (ja) | (e)-3-[2-(2-チエニル)ビニル]-1h-ピラゾールの固体形態 | |
| US8912214B2 (en) | Use of Chk2 kinase inhibitors for cancer treatment | |
| JPH05194491A (ja) | イミダゾリルメチル−ピリジン | |
| JP7235671B2 (ja) | H3リガンドの四水和物、その製造方法及びそれを含む医薬組成物 |